Drug Profile
AWD 12260
Alternative Names: IWF 12260Latest Information Update: 04 Feb 2000
Price :
$50
*
At a glance
- Originator elbion
- Class Cardiotonics; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Heart failure
Most Recent Events
- 04 Feb 2000 Discontinued-Preclinical for Arrhythmias in Germany (Unknown route)
- 04 Feb 2000 Discontinued-Preclinical for Heart failure in Germany (Unknown route)
- 17 Sep 1999 No-Development-Reported for Arrhythmias in Germany (Unknown route)